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Abstract
Background: Cardiovascular magnetic resonance (CMR) of the vessel wall is highly reproducible and can evaluate
both changes in plaque burden and composition. It can also measure aortic compliance and endothelial function
in a single integrated examination. Previous studies have focused on patients with pre-identified carotid atheroma.
We define these vascular parameters in patients presenting with coronary artery disease and test their relations to
its extent and severity.
Methods and Results: 100 patients with CAD [single-vessel (16%); two-vessel (39%); and three-vessel (42%) non-
obstructed coronary arteries (3%)] were studied. CAD severity and extent was expressed as modified Gensini score
(mean modified score 12.38 ± 5.3). A majority of carotid plaque was located in the carotid bulb (CB).
Atherosclerosis in this most diseased segment correlated modestly with the severity and extent of CAD, as
expressed by the modified Gensini score (R = 0.251, P < 0.05). Using the AHA plaque classification, atheroma class
also associated with CAD severity (rho = 0.26, P < 0.05). The distal descending aorta contained the greatest plaque,
which correlated with the degree of CAD (R = 0.222; P < 0.05), but with no correlation with the proximal
descending aorta, which was relatively spared (R = 0.106; P = n. s.). Aortic distensibility varied along its length with
the ascending aorta the least distensible segment. Brachial artery FMD was inversely correlated with modified
Gensini score (R = -0.278; P < 0.05). In multivariate analysis, distal descending aorta atheroma burden, distensibility
of the ascending aorta, carotid atheroma class and FMD were independent predictors of modified Gensini score.
Conclusions: Multimodal vascular CMR shows regional abnormalities of vascular structure and function that
correlate modestly with the degree and extent of CAD.
Keywords: Atherosclerosis, magnetic resonance imaging, coronary artery disease
Background
Imaging biomarkers have proven useful in the evaluation
of drugs used in the treatment of atherosclerosis [1,2]. A
variety of invasive and non-invasive techniques have
been applied to quantify plaque progression and
regression,[3-9] including compositional [10], and meta-
bolic changes [11]. The common goal is to extract reli-
able and reproducible quantitative data that yield
mechanistic insights in small numbers of patients and in
a short time frame.
Coronary artery atheroma burden can be estimated in
partially stenosed arteries with intravascular ultrasound
(IVUS) [8,12-14]. The principal drawback of IVUS is its
invasive nature, although serious complications (such as
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rare (< 0.5%), the use of IVUS is effectively limited to
the study of patients in whom coronary angiography is
clinically indicated. Because significant stenoses are gen-
erally treated with balloon angioplasty and stents, IVUS
is further confined to interrogation of non-stenotic seg-
ments (< 50%) of a different, single coronary artery.
B-mode (2-dimensional) ultrasound can quantify
thickening of the intima and media of carotid arteries
(CIMT), with high spatial resolution. CIMT is safe, non-
invasive, reproducible, quick and cheap to perform and
can be standardized for application in multiple centres
[15] and has been widely used in atherosclerosis treat-
ment trials [16-22] However, while providing quantita-
tive data on wall thickness, CIMT is limited to the
carotid arteries and does not provide useful information
on composition or function of the vessel wall.
Cardiovascular magnetic resonance (CMR) is emer-
ging as a useful complementary modality in the assess-
ment of response to therapy in atherosclerosis
[4,10,23,24]. Compared to existing approaches, CMR
offers several distinct advantages. Firstly, unlike CIMT,
CMR is a volumetric technique that is not confined to
single-plane imaging of the carotid arteries, but can be
used to interrogate volumes of the carotid arteries bilat-
erally, the aorta and the peripheral arteries. Unlike
IVUS, CMR is non-invasive, and does not require ionis-
ing radiation for catheter positioning. CMR is highly
reproducible and capable of evaluating changes in pla-
que volume in relatively small numbers of patients
[25-27]. Furthermore, CMR offers an opportunity to
measure not only plaque burden but also plaque compo-
sition [10,28-30] and to provide physiological assess-
ments of vascular function such as pulse wave velocity,
aortic compliance and endothelial function in the fore-
arm in a single integrated examination [24,31-33].
Previous studies did not take into account the distri-
bution of atheroma along the studied vessels and did
not quantitatively relate this to CAD extent or severity
on a per segment basis [34,35]. As CMR is poised to
become more widely applied for the evaluation of cardi-
ovascular drug therapies, it has become important to
define the relationship between MR derived indices of
peripheral vascular structure and function and coronary
disease.
Here, we determine (1) the extent and distribution of
atheroma burden in the carotid arteries and aorta, (2)
the degree and distribution of aortic distensibility, (3)
carotid artery composition, and (4) flow mediated vaso-
dilatation of the forearm, all measured by CMR, in
patients with CAD and relate these to the findings
obtained from clinically-driven coronary angiography.
This cohort is likely to be representative of the general
coronary artery disease population that comprises the
bulk of patients who will eventually receive atherosclero-
sis-modifying drugs.
Methods
Study population
Patients admitted for coronary angiography for investi-
gation of chest pain or abnormal non-invasive cardiac
investigations and who had also participated in a vascu-
lar CMR research protocol were eligible for inclusion.
This approach was designed to capture a cohort that
was representative of the spectrum of coronary disease
severity. All component studies were approved by the
Local Research Ethics Committee. Written informed
consent was obtained from all patients. Patients with
known chronic inflammatory conditions, infection,
malignancy, and contraindications to CMR scanning
were excluded.
Serum and plasma assays
Cholesterol and lipoprotein assays were performed using
aC o b a s - M i r aA n a l y s e r( A B XD i a g n o s t i c s ,S h e f f o r d ,
UK). Total cholesterol was assayed using the enzymatic
CHOD-PAP method and triglycerides were assayed
using the enzymatic GPO-PAP method. HDL-choles-
terol was assayed using a homogenous second genera-
tion PEGME method (Roche Diagnostics, Burgess Hill,
UK).
Coronary Angiography-Determination of the Severity of
Coronary Atherosclerosis
X-Ray coronary arteriography was performed by the
Judkins method. The severity (% stenosis) of coronary
artery atherosclerosis was systematically estimated
visually in each arterial segment, independently by two
experienced observers, blinded to the clinical and CMR
data. The coronary artery tree of each patient was
scored using the modified Gensini method [36]. In this
scoring system, a cumulative numeric score is deter-
mined by the degree of luminal narrowing and the ana-
tomical location of each stenosis. The modified Gensini
score has been described and validated previously [37].
The most severe stenosis in each of eight coronary seg-
ments was graded from 1 to 4 (1 = 1% to 49% lumen
diameter reduction; 2 = 50% to 74% stenosis; 3 = 75%
to 99% stenosis; 4 = 100% occlusion) to give a total
score of between 0 and 32. This score therefore gives a
measure that combines both the severity and extent of
coronary atherosclerosis.
CMR Scan-MR structural and functional vascular indices
CMR was performed on a 1.5 Tesla Sonata system (Sie-
mens, Erlangen) at a constant temperature and after at
least 20 minutes’ quiet rest. Blood pressure was moni-
tored using a sphygmomanometer.
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For assessment of atherosclerosis in the aorta, a stack of
11 transverse black blood turbo spin echo (TSE) images
covering the descending thoracic aorta was acquired
during diastole (sequence parameters: TR 1 R-R interval,
TE 11 ms, in-plane resolution 0.8 mm, slice thickness 5
mm). For assessment of atherosclerosis in the carotid
arteries, we obtained 11 black blood turbo spin echo
(TSE) cross-sectional images of both arteries, centred
1cm below the lowest point of the bifurcation (sequence
parameters: FOV 150 mm, TR 2 R-R intervals, TE 81
ms, resolution 0.5 mm × 0.5 mm in plane, slice thick-
ness 3 mm) (Figure 1).
All images were assessed using an image quality scor-
ing system that was based on a previously published
approach [38]. Images of quality score > 3 were ana-
lyzed. These images were segmented using semi-auto-
mated border detection algorithms developed using
Matlab software (Mathworks Inc.) in order to define the
inner (lumen) and outer vessel wall boundaries. Vessel
wall area (WA) was calculated from the difference
between these two contours, and also normalized to
external vessel area to yield plaque index (PI), as pre-
viously described [24].
Mean carotid and aortic WA and PI were produced by
averaging such measurements for the entire vessel (in
the case of carotid indices the left and right vessels were
combined to generate a mean value). To determine the
distribution of atheroma along these vessels we pro-
duced segmental average WA and PI measurements for
corresponding segments of the carotids [carotid bulb
(CB), distal common carotid (DCC), and proximal com-
mon carotid (PCC)] and the aorta [proximal descending
aorta (PDA), middle descending aorta (MDA) and distal
descending aorta (DDA)].
Carotid atheroma characterization
High resolution, black blood, proton density (TR/TE:
1200/12), T1 (TR/TE: 700/12), and T2 (TR/TE: 3200/81)
weighted turbo spin echo (TSE) and bright blood steady
state free precession imaging was used to characterize car-
otid plaque composition(in plane resolution 0.5 mm × 0.5
mm, slice thickness 3 mm for all types of images). Images
of each carotid vessel (covering 6 mm proximally and 6
A
B
C
D
E
F
Figure 1 (A-C) Carotid and (D-F) aortic segments. (A-C) Carotid and (D-F) aortic segments. Characteristic turbo spin echo vessel wall images
at the level of the proximal descending aorta (PDA) (a), middle descending aorta (MDA) (b), distal descending aorta (DDA) (c), carotid (bulb) (d),
distal common carotid (PCC) (e) and proximal common carotid (DCC) (f).
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sclerosis of the common carotid, carotid bulb, carotid
bifurcation and internal carotid artery. For each subject
the most severe plaque was identified and allocated a rank
based on the previously published Modified American
Heart Association (AHA) Atherosclerotic Plaque Classifi-
cation for CMR (ranging from 1-8).
Aortic distensibility
ECG-gated, steady state free precession (SSFP) ‘cine’
images were acquired during breath-hold to determine
aortic distensibility. The first was obtained at the level
of the right pulmonary artery through the ascending
and proximal descending aorta and the second through
the distal aorta below the diaphragm (CMR parameters:
repetition time (TR) 2.8 ms, echo time (TE) 1.4 ms, in-
plane resolution 2 mm, slice thickness 7 mm, temporal
resolution 40 ms). Maximum and minimum aortic
cross-sectional areas over the cardiac cycle were deter-
mined using semi-automated edge detection algorithms
developed using Matlab software (Mathworks Inc.) (25).
Distensibility was calculated as the relative change in
area divided by the pulse pressure. Aortic distensibility
was assessed at 3 levels of the thoracic aorta: ascending
(AA), proximal descending (PA) and distal descending
(DA) aorta. Semi automated software was used to track
the vessel boundary during the cardiac cycle and calcu-
late the relative cross-sectional area change in order to
estimate aortic distensibility.
Flow mediated dilatation
Steady state free precession (SSFP) acquisitions were
used to determine brachial artery reactivity, as pre-
viously described [31]. SSFP Cross-sectional images of
the brachial artery (typical parameters TR 6 ms, TE 3
ms, in-plane resolution 0.3 mm, slice thickness 3 mm)
were acquired at baseline and following release of a cuff
inflated to 50 mm Hg above systolic blood pressure on
the forearm for five minutes. After a 10-minute interval,
further brachial artery images were acquired following
administration of 400 micrograms of sublingual glyceryl
trinitrate (GTN). Post processing was performed using
semi-automated edge detection methods developed with
Matlab software (Mathworks Inc.). Maximum percen-
tage change in brachial artery cross-sectional area at
end-diastole was used to determine the response to each
stimulus as previously described.
Statistical analyses
Statistical analyses were carried out using SPSS version
15 (SPSS Inc.). Normal distribution of data was con-
firmed using the Kolmogorov-Smirnov test. Not Nor-
mally distributed data were logarithmically transformed
for analysis. Normally distributed data are presented as
mean ± standard error while not normally distributed
data are presented as median (25
th,7 5
th percentile).
One-way and repeated measures Analysis of Variance
(ANOVA) with Bonferroni post hoc comparisons, Fried-
man’s test, paired t tests and independent t test were
used to compare numerical variables between groups as
appropriate, while the chi-squared test was used for
categorical variables. Pearson’sc o e f f i c i e n tw a su s e df o r
univariate correlation analysis. Stepwise multivariate
regression analysis with backward elimination of inde-
pendent variables was applied for the analysis of the
association between CAD extent/severity and each of
the MR derived vascular measures that had a significant
univariate correlations with Gensini score. Independent
variables were entered in the model if the level of signif-
icance of their correlation with the dependent variable
was P < 0.05, while correlations were regarded as inde-
pendent for variables retained in the model and reaching
a P < 0.05 level of significance.
Results
The study population comprised 100 patients who had
undergone clinically-driven coronary angiography and
who had participated in a vascular CMR research proto-
col (Table 1 for clinical characteristics). Accordingly, the
population included patients with: single-vessel (16%);
two-vessel (39%); and three-vessel (42%) coronary dis-
ease and non-obstructed coronary arteries (3%). The
Table 1 Clinical characteristics and risk factors.
Patient Characteristics
Age 64.17 (± 0.78)
Gender Male 88/100
Diabetes mellitus (1 or 2) 40/100
Hypertension 77/100
Smoking history 60/100
Hyperlipidemia 86/100
Total cholesterol 4.21 (± 0.09)
LDL 2.44 (± 0.09)
HDL 1.11 (± 0.03)
Triglycerides 1.87 (± 0.1)
Body mass index (BMI) 28.32 (± 0.41)
Aspirin 91/100
Clopidogrel 33/100
Statins 96/100
ACE inhibitors/ARBs 62/100
Beta blockers 86/100
Diuretics 26/100
Nitrates 13/100
Calcium channel blockers 28/100
Insulin 13/100
Oral hypoglycemic agents 26/100
Kylintireas et al. Journal of Cardiovascular Magnetic Resonance 2011, 13:61
http://www.jcmr-online.com/content/13/1/61
Page 4 of 11mean modified Gensini score was 12.38 ± 5.3 (range: 4
to 21).
Carotid atheroma
In total, 2200 vessel MR images were obtained, of which
1520 were included in the analysis (69%). Vessels were
excluded if fewer than 6 images met the inclusion thresh-
old for analysis. This yielded 151 adequately imaged ves-
sels (76 right and 77 left carotid arteries) out of the
original 200. 83% of patients had at least 1 carotid artery
amenable to analysis. The principal reason for exclusion
was poor distinction between the outer vessel wall and
the surrounding structures, rendering accurate wall area
quantification impossible. The mean wall area was 29.8
mm
2 and the mean plaque index 0.42 (± 0.004). Mean
wall area, but not mean plaque index, was slightly higher
in the right compared to the left carotid artery [RCA wall
area = 31.1 (25.5 - 35.8) mm
2 vs. LCA wall area = 29.6
(25.3 - 34.1; P < 0.05] [RCA plaque index = 0.41 (±
0.004) vs. LCA plaque index = 0.42 (± 0.005) mm
2 ,n o t
significant]. Inter-observer variability between the opera-
tors for wall area was < 4%. Intra-observer variability was
< 1% on the images accepted for analysis.
Taken as a whole, there was no correlation between
the mean wall area of the carotid arteries and the extent
of coronary atheroma indicated by the modified Gensini
score (R = 0.177, P = n.s.).
Segmental distribution of carotid atheroma
Examination of the segmental distribution of atheroma
along the carotid artery revealed that the majority of
carotid plaque was located in the carotid bulb (CB) (Fig-
ure 2A and 2B). Mean carotid bulb wall area correlated
with the severity and extent of CAD, as expressed by
the modified Gensini score (R = 0.251, P < 0.05). There
was no association between the modified Gensini score
and wall area of the proximal and distal common
carotid.
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Figure 2 Distribution of carotid and aortic plaque. Distribution of carotid and aortic plaque. Atheroma burden (expressed as wall and plaque
index) was higher in the carotid bulb (CB) compared to the distal (DCC) and proximal segments of common carotid (PCC) artery (A and B).
Atheroma burden (expressed as wall area and plaque index) was higher in the distal (DDA) and middle descending (MDA) aorta in comparison
to the proximal descending aorta (PDA) (C and D).
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Page 5 of 11Carotid atheroma classification
On the basis of our image quality system we included in
the analysis patients with adequate quality (vessel image
score ≥ 3) visualization of the common carotid, bifurca-
tion and internal carotid of at least one of their vessels.
80/100 patients had adequate imaging of at least one
vessel and 75/100 had 2 assessable carotid arteries
(Additional file 1: flow chart 1). Maximal carotid ather-
oma class was: I-II (normal and near-normal circumfer-
ential thickening) for 11/80 (13.75%), III (focal
thickening) for 34/80 (42.5%), IV-V (lipid core) for 20/
80 (25%), VI (plaque hemorrhage and fibrous cap rup-
ture) for 10/80 (12.5%), VII (calcified plaque) for 3/80
(3.75%), VIII (fibrotic plaque) for 2/80 (2.5%). Maximal
carotid atheroma class was associated with CAD severity
(rho = 0.26, P < 0.05) (Figure 3).
Aortic atheroma
Vessels of which < 6 images were analysable were
excluded, the principal reason for exclusion being poor
distinction between the outer vessel wall and the sur-
rounding structures. In total, 807 out of 1100 (73%) aor-
tic cross-sectional images were included in the analysis.
This corresponded to 96 interpretable studies out of 100
obtained (Additional file 1: flow chart 1). The mean wall
area was 168.3 (150.5 - 193.9) mm
2 and the mean pla-
que index was 0.3 (± 0.003). Inter-observer variability
between the operators for wall area was < 3%. Intra-
observer variability was < 1%. There was no significant
correlation between mean aortic wall area and the sever-
ity of CAD (R = 0.198, P = n.s.).
Segmental distribution of aortic atheroma
When aortic segments were considered the middle and
distal descending aorta slices contained the greatest
volume of plaque in comparison with the proximal des-
c e n d i n ga o r t a( s e eF i g u r e2 C, &2D). As for the carotid
arteries, a significant correlation emerged between CAD
severity and wall area measured in the more diseased
segments of aorta. For the middle descending aorta (R =
0.208; P < 0.05) and for the distal descending aorta (R =
0.222; P < 0.05), but with no correlation with the proxi-
mal descending aorta, which was relatively spared (R =
0.106; P = n. s.).
Regional aortic distensibility analysis
Aortic distensibility varied progressively along its
length (ascending aorta: 1.8 ± 0.12 × 10
-3 mmHg
-1,
proximal descending aorta: 2.5 ± 0.14 × 10
-3 mmHg
-1,
distal descending aorta: 3.4 ± 0.21 × 10
-3 mmHg
-1),
with the ascending aorta being the least distensible
segment (Figure 4).
FMD vs. coronary atherosclerosis
Mean FMD in this population was 8.4 (0.7)%. Brachial
artery FMD inversely correlated with modified Gensini
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Figure 3 Maximal carotid atheroma class vs. CAD severity. Maximal carotid atheroma class vs. CAD severity. Maximal carotid atheroma class
was positively associated with CAD severity.
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Figure 4 Aortic distensibility along the thoracic aorta. Aortic distensibility along the thoracic aorta. Of the three sites assessed [ascending
(AA), proximal descending (PA) and distal descending (DA) aorta], distensibility was lowest at the AA and highest at the DA.
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Figure 5 Relationship of endothelial function, assessed by flow mediated vasodilatation of the brachial artery and extent of coronary
artery disease. Relationship of endothelial function, assessed by flow mediated vasodilatation of the brachial artery and extent of coronary
artery disease. FMD inversely correlated with CAD extent and severity (as expressed by modified Gensini score).
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Page 7 of 11score (R = -0.278; P < 0.05) indicating a quantitative
relationship between the CAD severity and the degree
of endothelial dysfunction (Figure 5).
Multivariate analysis
Using multivariate regression analysis with inclusion
of anthropometric (body mass index, waist hip ratio)
and demographic data (age, gender), cardiovascular
risk factors and MR indices as independent variables,
as appropriate, none of the carotid plaque measure-
ments and none of the classical risk factors emerged
as independent predictors of modified Gensini score.
Distal descending aorta atheroma burden, distensibil-
ity of the ascending aorta, maximal carotid atheroma
class and FMD were the only independent predictors
of modified Gensini score [b (SE) = 10.34 (0.08), P <
0.05, b (SE) = -7.29 (5.08), P < 0.005, b (SE) = 0.7
(0.3), P < 0.05 and b (SE) = -0.19 (0.08), P < 0.05
respectively] (Table 2).
Discussion
We report the multimodal vascular CMR characteris-
tics of 100 patients that represent a spectrum of cor-
onary artery severity. In this clinically relevant cohort,
we identify regional variations in both (i) the distribu-
tion of atherosclerosis in the aorta and carotid arteries
and (ii) aortic distensibility, measured at three sites.
For both carotid arteries and aorta, plaque burden of
only the most diseased segments correlated modestly
with the extent and severity of coronary disease. We
also detect, for the first time, a relationship between
increasing carotid atheroma complexity, characterized
by CMR, and CAD extent/severity. The AHA atheroma
classification based on histological features reflects in
part the sequential development of atheromatous
lesions [39]. On this basis, although plaques bearing
features of vulnerability (i.e. IV-VI) are associated
with higher risk of thromboembolism and cardiovascu-
lar events, higher class atheroma (i.e.VII-VIII) corre-
sponds to more advanced atherosclerosis. The modest
association that we detect between carotid atheroma
classification and Gensini score is therefore pathophy-
siologically consistent with this theoretical scheme.
Atherosclerosis imaging
According to conventional approaches to MR determi-
nation of atheroma burden, per patient measurements
are derived by averaging or summation across the full
extent of imaged aorta and/or the combined carotid ves-
sels [4,9]. However, the current study demonstrates a
propensity for MR-determined plaque in the carotid
bulb and the practice of averaging along the vessel may
diminish artificially the true range of plaque burden and
thereby reduce the power for quantitative comparisons.
The significance of the regional variation in distribution
is further reinforced by the relationship with coronary
atherosclerosis, estimated using a modified version of
the Gensini scoring system. By virtue of being deter-
mined by both (i) the degree of coronary stenoses and
(ii) the number of stenosed segments, this score pro-
vides an insight in the extent of coronary disease. Uni-
variate analysis revealed that atheroma burden of the
common carotid did not correlate with CAD severity,
while only a modest correlation with atheroma of the
carotid bulb was detected. This result is consistent with
previous reports of a selective relationship between
ultrasonographic atheroma measurements at that level
and angiographic coronary disease estimates [40]. The
correlation with angiographically-determined coronary
disease was weak but comparable with that found in
studies of ultrasound-measured IMT vs.q u a n t i t a t i v e
coronary angiography [40]. No more than a modest cor-
relation is to be expected, since CMR measures within-
wall plaque volume, while coronary angiography esti-
mates plaque extent based on the two-dimensional pro-
jection of lesions that encroach into the vessel lumen,
with very limited ability to estimate the true size of pla-
ques. Furthermore, patientsi n c l u d e di nt h i ss t u d yh a d
symptomatic angina; biasing inclusion to the presence of
at least one flow-limiting coronary stenosis, irrespective
of total coronary plaque burden. A recent study measur-
ing intima media thickness along several segments of
the carotid using ultrasound has not only confirmed sig-
nificant differences in atheroma accumulation between
segments but also demonstrated a selectively stronger
relationship between coronary atherosclerosis and caro-
tid intima media measurements at the level of the caro-
tid bulb/bifurcation [40]. The importance of focusing
segments of artery with most abundant atherosclerosis
is further emphasized by the recent observation that lar-
ger wall areas show the greatest propensity for change
(both regression and progression) over time [41].
Furthermore, larger plaques may show greater composi-
tional heterogeneity, presenting an opportunity to quan-
tify both total plaque size and lipid rich core [10,42].
Previous CMR studies of carotid atherosclerosis have
largely focused on patients selected for the presence of
significant carotid disease [38,43]. Using such an
Table 2 Independent Predictors of Gensini score
Predictors (R
2 = 0.17) b (SE) P
Distal descending aorta wall area 10.34 (0.08) < 0.05
Ascending Aorta distensibility -7.29 (5.08) < 0.005
FMD -0.19 (0.08) < 0.05
Maximal Carotid Atheroma Class 0.7 (0.3) < 0.05
Using multivariate regression analysis, Maximal Carotid Atheroma Class, distal
descending aorta atheroma burden, distensibility of the ascending aorta and
FMD were independent predictors of modified Gensini score.
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appearances with histological examination of explanted
endarterectomy material, it has been possible to deter-
mine and validate the use of multi-contrast-CMR for
the assessment of plaque size and composition. The cur-
rent study extends this analysis to patients that are more
representative of the general coronary artery disease
population and defines their CMR-derived vascular
characteristics.
Physiological measures
Aortic distensibility, determined by CMR is diminished
in smokers;[31] type 2 diabetes;[32] and obesity [44]. In
the Multi-Ethnic Study of Atherosclerosis, aortic disten-
sibility at a single level was associated with increasing
cardiovascular risk factors [45]. Importantly, distensibil-
ity varies over a substantial ‘dynamic range’ and can
show improvement in response to treatment in a short
time frame [9,44]. The measurement of lumen cross-
sectional area is readily obtained using automated,
highly reproducible techniques [46]. Here, we show
marked regional differences in distensibility in patients
with coronary artery disease. The reasons for diminished
distensibility may not be simply explained. We and
others have found that in some patients reduced disten-
sibility is related to increased wall thickness, however
this relationship does not hold in patients with diabetes
where distensibility may be reduced to due composi-
tional changes in the vessel wall, for instance due to
cross linking of structural proteins by advanced glyca-
tion end products [32,47,48]. However, as we are nor-
malizing distensibility measured at all three aortic sites
to the same peripherally measured pulse pressure, the
observed differences may not be directly related to vas-
cular wall structure differences but rather to central
pulse pressure differences along the length of the aorta.
When testing the association with CAD severity we
found that the relationship was only modest and limited
to the ascending aorta.
Finally, the demonstrated lower variability of MR
based FMD measurement in comparison to the corre-
sponding ultrasonographic technique may account for
detection of a modest, yet significant and independent,
relationship between CAD severity and endothelial dys-
function in this study [49].
Utility
CMR confers the ability to obtain multiple complemen-
tary measures of vascular structure and function in an
integrated examination. This ability will enable the char-
acterization of patients with different stages of disease
who are likely to manifest a spectrum of vascular struc-
tural and functional dysfunction and to respond differ-
ently to given interventions. There is potential benefit in
knowing which vascular segments and vascular para-
meters assessable by MR should be prioritized for speci-
fic studies, especially as part of a time consuming
protocol and relatively expensive technique. We suggest
that these results can help define MR scanning
priorities.
Conclusion
In patients with angiographic coronary artery disease,
vascular CMR of the carotid arteries and aorta show
atherosclerosis that is mostly apparent in the carotid
bulb and distal descending aorta. Only the extent of
plaque in these most diseased segments modestly cor-
related with the extent and severity of coronary dis-
ease. There were modest, yet independent, associations
between CAD extent/severity and increasing carotid
atheroma complexity, endothelial dysfunction and
ascending aorta stiffening, as characterized by CMR.
As CMR assumes greater importance for assessment of
vascular structure and function, the parameters
reported here will better inform the design of clinical
trials.
Additional material
Additional file 1: Flow chart 1- Vessel wall image quality. Flow chart
highlighting the image quality criteria and demonstrating the image
selection process for analysis of plaque burden (of the aorta and the
carotids) and plaque composition (of the carotid arteries).
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